Reactions Weekly

, Volume 1633, Issue 1, pp 534–534 | Cite as

Multiple drugs

Various toxicities: 2 case reports
Case report


  1. Delacruz W, et al. Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature. Case Reports in Oncological Medicine 2016: 2016. Available from: URL: - USA

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations